» Articles » PMID: 33872376

HPF1-dependent PARP Activation Promotes LIG3-XRCC1-mediated Backup Pathway of Okazaki Fragment Ligation

Overview
Specialty Biochemistry
Date 2021 Apr 19
PMID 33872376
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

DNA ligase 1 (LIG1) is known as the major DNA ligase responsible for Okazaki fragment joining. Recent studies have implicated LIG3 complexed with XRCC1 as an alternative player in Okazaki fragment joining in cases where LIG1 is not functional, although the underlying mechanisms are largely unknown. Here, using a cell-free system derived from Xenopus egg extracts, we demonstrated the essential role of PARP1-HPF1 in LIG3-dependent Okazaki fragment joining. We found that Okazaki fragments were eventually ligated even in the absence of LIG1, employing in its place LIG3-XRCC1, which was recruited onto chromatin. Concomitantly, LIG1 deficiency induces ADP-ribosylation of histone H3 in a PARP1-HPF1-dependent manner. The depletion of PARP1 or HPF1 resulted in a failure to recruit LIG3 onto chromatin and a subsequent failure in Okazaki fragment joining in LIG1-depleted extracts. Importantly, Okazaki fragments were not ligated at all when LIG1 and XRCC1 were co-depleted. Our results suggest that a unique form of ADP-ribosylation signaling promotes the recruitment of LIG3 on chromatin and its mediation of Okazaki fragment joining as a backup system for LIG1 perturbation.

Citing Articles

CRISPR/Cas9 screens identify LIG1 as a sensitizer of PARP inhibitors in castration-resistant prostate cancer.

Fracassi G, Lorenzin F, Orlando F, Gioia U, DAmato G, Casaramona A J Clin Invest. 2024; 135(4).

PMID: 39718835 PMC: 11827843. DOI: 10.1172/JCI179393.


The prognostic value and biological significance of MRI CE-T1-based radiomics models in CNS5-identified GBM: a multi-center study.

Zhang M, Li X, Yang Y, Wang X, Li S, Yue Q Sci Rep. 2024; 14(1):27551.

PMID: 39528608 PMC: 11554799. DOI: 10.1038/s41598-024-78705-8.


CDK-dependent phosphorylation regulates PNKP function in DNA replication.

Mashayekhi F, Zeinali E, Ganje C, Fanta M, Li L, Godbout R J Biol Chem. 2024; 300(11):107880.

PMID: 39395804 PMC: 11650725. DOI: 10.1016/j.jbc.2024.107880.


Inactive Parp2 causes Tp53-dependent lethal anemia by blocking replication-associated nick ligation in erythroblasts.

Lin X, Gupta D, Vaitsiankova A, Bhandari S, Leung K, Menolfi D Mol Cell. 2024; 84(20):3916-3931.e7.

PMID: 39383878 PMC: 11615737. DOI: 10.1016/j.molcel.2024.09.020.


is a novel marker for bladder cancer prognosis: evidence based on experimental studies, machine learning and single-cell sequencing.

Song D, Shen T, Feng K, He Y, Chen S, Zhang Y Front Immunol. 2024; 15:1419126.

PMID: 39234248 PMC: 11371609. DOI: 10.3389/fimmu.2024.1419126.


References
1.
Vijayakumar S, Chapados B, Schmidt K, Kolodner R, Tainer J, Tomkinson A . The C-terminal domain of yeast PCNA is required for physical and functional interactions with Cdc9 DNA ligase. Nucleic Acids Res. 2007; 35(5):1624-37. PMC: 1865074. DOI: 10.1093/nar/gkm006. View

2.
Jonsson Z, Hindges R, Hubscher U . Regulation of DNA replication and repair proteins through interaction with the front side of proliferating cell nuclear antigen. EMBO J. 1998; 17(8):2412-25. PMC: 1170584. DOI: 10.1093/emboj/17.8.2412. View

3.
Tomkinson A, Totty N, GINSBURG M, Lindahl T . Location of the active site for enzyme-adenylate formation in DNA ligases. Proc Natl Acad Sci U S A. 1991; 88(2):400-4. PMC: 50818. DOI: 10.1073/pnas.88.2.400. View

4.
Suskiewicz M, Zobel F, Ogden T, Fontana P, Ariza A, Yang J . HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation. Nature. 2020; 579(7800):598-602. PMC: 7104379. DOI: 10.1038/s41586-020-2013-6. View

5.
Johnston L, Nasmyth K . Saccharomyces cerevisiae cell cycle mutant cdc9 is defective in DNA ligase. Nature. 1978; 274(5674):891-3. DOI: 10.1038/274891a0. View